Opinion|Videos|February 26, 2025
Management of Hyperlipidemia and Weight Gain with Lorlatinib
Key opinion leaders discuss experiences managing weight gain with lorlatinib, addressing its impact on quality of life versus treatment benefits.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What has been your experience managing weight gain with lorlatinib?
- How do you address the impact of weight gain on quality of life compared to treatment benefits?
Advertisement
Related to this article
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Daraxonrasib and RAS Inhibition: What Oncology Nurses Need to Know
2
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
3
Education, Infection Vigilance Define Outpatient Bispecific Care
4
Childhood Leukemia Treatment Disrupts Work, Finances for Most Families
5